arrow
返回
M

Millie D. Long

Vitalant Research Institute

56H指数
589论文数
1.2W被引数
收录论文 157
发表时间
Body Mass Index Did Not Affect Efficacy and Safety of Etrasimod: A Post Hoc Analysis of the ELEVATE Ulcerative Colitis Clinical Program体重指数未影响依特拉西莫德的有效性和安全性:ELEVATE UC 临床项目的事后分析
err2025-11-01
err1
PREAI
errYarur, Andres J.; Long, Millie D.; Torres, Joana; Nandi, Neilanjan; Cross, Raymond K.; Abbatemarco, Arcangelo M.; Blanco, David; Niezychowski, Wojciech; Crosby, Catherine; Wu, Joseph; Pradeep, Gokul; Goetsch, Martina; Panaccione, Remo
err分享
err收藏
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age奥扎尼妥(Ozanimod)在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性
err2025-11-01
err0
PREAI
errFaye, Adam S.; Rubin, David T.; Siegel, Corey A.; Long, Millie D.; Khan, Nabeel; Danese, Silvio; Irving, Peter M.; Cross, Raymond K.; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N.; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, Annkatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N.; Sabino, Joao
err分享
err收藏
Pharmacokinetics and Exposure-Response Relationships of Guselkumab Intravenous or Subcutaneous Induction in Participants With Ulcerative ColitisGuselkumab静脉或皮下诱导给药在溃疡性结肠炎患者中的药代动力学及暴露-反应关系
err2025-10-01
err0
PREAI
errPeyrin-Biroulet, Laurent; Xu, Zhenhua; Shao, Jie; Hisamatsu, Tadakazu; Long, Millie D.; Danese, Silvio; Germinaro, Matthew; Vetter, Marion L.; Yarandi, Shadi; Baker, Thomas; Allegretti, Jessica R.; Rubin, David T.
err分享
err收藏
Missing the Mark: Treat-to-Target Gaps in Real-World Ulcerative Colitis Care未达标:真实世界中溃疡性结肠炎治疗目标存在的差距
err2025-10-01
err0
PREAI
errLong, Millie D.; Salinas, Yasmmyn D.; Bufford, Teresa; Crawford, Julie M.; Gazis, Derek R.; Hurwitz, Kathleen; Igho-Osagie, Ebuwa; Liu, Gui; Shao, Jeremy; Sands, Bruce E.
err分享
err收藏
Predictors of Response to Ustekinumab and Identification of Factors Associated With Dose Escalation in Patients With Inflammatory Bowel Disease乌司奴单抗治疗应答的预测因子及炎症性肠病患者剂量加倍的关联因素识别
err2025-10-01
err0
PREAI
errAxelrad, Jordan; Horst, Sara; Bennett, Audrey; Ashokan, Anagha; Hudhud, Dania; Wu, Angela; Long, Millie D.; Anderson, Chelsea; Chaudhary, Vasantham; Axenfeld, Ellen M.; Cross, Raymond K.
err分享
err收藏
Impact of Subcutaneous Guselkumab Induction Therapy on Molecular Inflammation in Patients With Ulcerative Colitis: Results From the Phase 3 ASTRO Study皮下注射古塞库单抗诱导治疗对溃疡性结肠炎患者分子炎症的影响:ASTRO III期研究结果
err2025-10-01
err0
PREAI
errVenkat, Swati; Sridhar, Sunandini; Shaikh, Barbara; Sohn, Klebea; Liu, Jared; Sisk, Christopher; McRae, Bradford; Alvarez, Yelinia; Baker, Thomas; Germinaro, Matthew; Allegretti, Jessica R.; Long, Millie D.; Rubin, David T.; Peyrin-Biroulet, Laurent; Hart, Amy; Branigan, Patrick
err分享
err收藏
err分享
err收藏
Prolonged Pharmacodynamic Effects of Risankizumab Following Withdrawal in Patients with Moderately to Severely Active Ulcerative Colitis
err2025-01-22
err0
PREAI
errRubin, D. T.; Allegretti, J. R.; Demasi, R.; Crowley, J.; Chen, S.; Winzenborg, I; Guay, H.; D'Cunha, R.; Long, M.
err分享
err收藏
P0894 Impact of Mirikizumab on Extraintestinal Manifestations of Crohn's Disease in the VIVID-1 Study
err2025-01-22
err0
PREAI
errVavricka, S. R.; Ananthakrishnan, A.; Long, M.; Melmed, G.; Narula, N.; Rubin, D.; Hon, E.; Carlier, H.; Moses, R.; Yu, G.; Zang, H.; Kucharzik, T.
err分享
err收藏